Search details
1.
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.
Cancer Immunol Immunother
; 72(7): 2357-2373, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36939854
2.
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
Nature
; 543(7647): 714-718, 2017 03 30.
Article
in English
| MEDLINE | ID: mdl-28329761
3.
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival.
Breast Cancer Res
; 24(1): 43, 2022 06 24.
Article
in English
| MEDLINE | ID: mdl-35751095
4.
The circular RNome of primary breast cancer.
Genome Res
; 29(3): 356-366, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30692147
5.
ramr: an R/Bioconductor package for detection of rare aberrantly methylated regions.
Bioinformatics
; 38(1): 133-140, 2021 12 22.
Article
in English
| MEDLINE | ID: mdl-34383893
6.
Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer.
Biomarkers
; 26(4): 302-308, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33645339
7.
Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma.
BMC Cancer
; 19(1): 11, 2019 Jan 05.
Article
in English
| MEDLINE | ID: mdl-30611220
8.
Signatures of mutational processes in human cancer.
Nature
; 500(7463): 415-21, 2013 Aug 22.
Article
in English
| MEDLINE | ID: mdl-23945592
9.
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.
PLoS Genet
; 12(7): e1006225, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27472274
10.
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.
Ann Intern Med
; 168(5): 326-334, 2018 03 06.
Article
in English
| MEDLINE | ID: mdl-29335712
11.
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors.
Int J Mol Sci
; 20(17)2019 Aug 29.
Article
in English
| MEDLINE | ID: mdl-31470659
12.
APOBEC3A/B deletion polymorphism and cancer risk.
Carcinogenesis
; 39(2): 118-124, 2018 02 09.
Article
in English
| MEDLINE | ID: mdl-29140415
13.
Introducing nano-scale quantitative polymerase chain reaction.
Biochem Biophys Res Commun
; 506(4): 923-926, 2018 12 02.
Article
in English
| MEDLINE | ID: mdl-30392909
14.
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
Genome Res
; 25(6): 814-24, 2015 06.
Article
in English
| MEDLINE | ID: mdl-25963125
15.
High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.
BMC Cancer
; 18(1): 684, 2018 Jun 25.
Article
in English
| MEDLINE | ID: mdl-29940909
16.
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.
BMC Cell Biol
; 18(1): 17, 2017 04 17.
Article
in English
| MEDLINE | ID: mdl-28415963
17.
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.
Breast Cancer Res Treat
; 163(1): 177-190, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28213783
18.
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.
BMC Cancer
; 17(1): 97, 2017 02 03.
Article
in English
| MEDLINE | ID: mdl-28158999
19.
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
Int J Cancer
; 139(3): 647-56, 2016 08 01.
Article
in English
| MEDLINE | ID: mdl-26991344
20.
The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Tumour Biol
; 37(8): 10697-702, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-26867771